Cargando…
Immunoregulation of Shenqi Fuzheng Injection Combined with Chemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis
Background. Immunosuppression is a well-recognised complication of chemotherapy in cancer patients. We assemble the clinical evidence that SQI, an adjuvant drug for lung cancer and gastric cancer which was widely prescribed in China, interventions could increase objective tumour response and regulat...
Autores principales: | Yang, Yang, Ting, Wang, Xiao, Liu, Shufei, Fu, Wangxiao, Tan, Xiaoying, Wang, Xiumei, Gao, Boli, Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244024/ https://www.ncbi.nlm.nih.gov/pubmed/28154607 http://dx.doi.org/10.1155/2017/5121538 |
Ejemplares similares
-
Shenqi Fuzheng Injection Combined With Chemotherapy for Gastric Cancer: An Overview of Systematic Reviews and Meta-Analyses
por: Xu, Jing, et al.
Publicado: (2023) -
Shenqi Fuzheng Injection Combined with Chemotherapy for Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Lv, Yanhong, et al.
Publicado: (2015) -
ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis
por: Xu, Rongzhong, et al.
Publicado: (2017) -
Effectiveness and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis
por: Qiao, Chenxi, et al.
Publicado: (2023) -
ShenQi FuZheng injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis
por: Zhang, Hongbo, et al.
Publicado: (2019)